Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy
Silvia D’Amico, Patrizia Tempora, Ombretta Melaiu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23

Showing 23 citing articles:

Cancer immune escape: the role of antigen presentation machinery
Anoop Kallingal, Mateusz Olszewski, Natalia Maciejewska, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 10, pp. 8131-8141
Open Access | Times Cited: 63
Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities
Mona Meng Wang, Sarah E. Coupland, Tero Aittokallio, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 8, pp. 1212-1224
Open Access | Times Cited: 48
ERAP Inhibitors in Autoimmunity and Immuno-Oncology: Medicinal Chemistry Insights
Vasileios Fougiaxis, Ben He, Tuhina Khan, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11597-11621
Open Access | Times Cited: 10
Efficacy of Anti-Cancer Immune Responses Elicited Using Tumor-Targeted IL-2 Cytokine and Its Derivatives in Combined Preclinical Therapies
Sahar Balkhi, Giorgia Bilato, Andrea De Lerma Barbaro, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 69-69
Open Access | Times Cited: 1
Genetic differences between smokers and never-smokers with lung cancer
Piotr Kuśnierczyk
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma
Patrizia Tempora, Silvia D’Amico, Paula Gragera, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 4
Revolutionary Cancer Therapy for Personalization and Improved Efficacy: Strategies to Overcome Resistance to Immune Checkpoint Inhibitor Therapy
Saud Almawash
Cancers (2025) Vol. 17, Iss. 5, pp. 880-880
Open Access
Monoclonal antibody immune therapy response instrument for stratification and cost-effective personalized approaches in 3PM-guided pan cancer management
Salem Baldi, Mohammed Alnaggar, Maged AL-Mogahed, et al.
The EPMA Journal (2025)
Closed Access
Beta-Defensin1 from Ctenopharyngodon idella exerts immunomodulatory effects through CiHsp70-mediated antigen processing and presentation pathway activation
Shoulin Cao, Jiaojiao Chang, Jinnian Li, et al.
Fish & Shellfish Immunology (2025) Vol. 162, pp. 110367-110367
Closed Access
A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers
Hongping Guo, Wenhao Cao, Yiran Zhu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 6
A luminescence-based method to assess antigen presentation and antigen-specific T cell responses for in vitro screening of immunomodulatory checkpoints and therapeutics
Jimena Álvarez Freile, Yuzhu Qi, Lisa Jacob, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Transcriptome analysis reveals immune regulation in the spleen of koi carp (Cyprinus carpio Koi) during Aeromonas hydrophila infection
Shuang Wang, Mei Li, Yu Jiang, et al.
Molecular Immunology (2023) Vol. 162, pp. 11-20
Closed Access | Times Cited: 5
Enhancing immunotherapy through PD‐L1 upregulation: the promising combination of anti‐PD‐L1 plus mTOR inhibitors
Anna Hernández‐Prat, Alejo Rodríguez‐Vida, Laura Cardona, et al.
Molecular Oncology (2024)
Open Access | Times Cited: 1
Subclonal accumulation of immune escape mechanisms in microsatellite instability-high colorectal cancers
Yuta Kobayashi, Atsushi Niida, Satoshi Nagayama, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 7, pp. 1105-1118
Open Access | Times Cited: 2
Structure‐guided discovery of aminopeptidase ERAP1 variants capable of processing antigens with novel PC anchor specificities
Suchita Pande, Hwai‐Chen Guo
Immunology (2023) Vol. 171, Iss. 1, pp. 131-145
Open Access | Times Cited: 1
Birinapant Reshapes the Tumor Immunopeptidome and Enhances Antigen Presentation
Weiyan Zhang, Shenghuan Sun, Wen‐Yuan Zhu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3660-3660
Open Access
Integrated machine learning survival framework to decipher diverse cell death patterns for predicting prognosis in lung adenocarcinoma
Fangchao Zhao, Xu Zhang, Yanhua Tian, et al.
Genes and Immunity (2024) Vol. 25, Iss. 5, pp. 409-422
Closed Access
Microproteins unveiling new dimensions in cancer
Daisy S Precilla, Indrani Biswas, T. S. Anitha, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 5
Closed Access
Platycodin D reduces PD‐L1 levels by inhibiting LXR‐β activity and combines with nintedanib to enhance the tumor‐killing effect of T cells
Jin Lei, Xue‐Wei Cao, Pengfei Li, et al.
FEBS Letters (2024)
Closed Access
The membrane-associated ubiquitin ligase MARCHF8 promotes cancer immune evasion by degrading MHC class I proteins
M. I. Khalil, Jie Wang, Canchai Yang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Comprehensive Longitudinal ctDNA Monitoring in Metastatic Cancer Patients Treated with an Individualized Neoantigen-directed Vaccine
Desiree Schenk, Matthew J. Davis, Rita Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Oncolytic Virus: A Promising Immunotherapy to Treat Tumors
Anthony Rosen
Science Insights (2023) Vol. 42, Iss. 2, pp. 801-805
Open Access
New Curcuphenol Analogues Possess Anti-Metastatic Biological Activity
Samantha L. S. Ellis, Lilian L. Nohara, Sarah Dada, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top